ANNX - Annexon  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANNX is currently covered by 7 analysts with an average price target of $10.09. This is a potential upside of $7.98 (378.2%) from yesterday's end of day stock price of $2.11.

Annexon 's activity chart (see below) currently has 13 price targets and 52 ratings on display. The stock rating distribution of ANNX is 91.89% BUY and 8.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.52% with an average time for these price targets to be met of 85.86 days.

Highest price target for ANNX is $14, Lowest price target is $11, average price target is $12.4.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 14-May-2025. First documented stock forecast 18-Aug-2020.

Currently out of the existing stock ratings of ANNX, 34 are a BUY (91.89%), 3 are a HOLD (8.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

$11.89 (563.51%)

11 days ago
(14-May-2025)

0/4 (0%)

$12.24 (695.45%)

Buy

$11

$8.89 (421.33%)

$16

12 days ago
(13-May-2025)

0/13 (0%)

$9.25 (528.57%)

Buy

6 months 10 days ago
(15-Nov-2024)

0/5 (0%)

$10.05 (340.68%)

Buy

$14

$11.89 (563.51%)

$10

11 months 20 days ago
(05-Jun-2024)

0/4 (0%)

$7.21 (106.19%)

Buy

$12

$9.89 (468.72%)

$10

11 months 21 days ago
(04-Jun-2024)

4/6 (66.67%)

$6.01 (100.33%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ANNX (Annexon ) average time for price targets to be met?

On average it took 85.86 days on average for the stock forecasts to be realized with a an average price target met ratio 19.52

Which analyst has the current highest performing score on ANNX (Annexon ) with a proven track record?

TAZEEN AHMAD

Which analyst has the current lower performing score on ANNX (Annexon ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on ANNX (Annexon )?

Tazeen Ahmad works at BAML and has 16 price targets and 11 ratings on ANNX

Which analyst is the currently most bullish on ANNX (Annexon )?

Derek Archila with highest potential upside - $11.89

Which analyst is the currently most reserved on ANNX (Annexon )?

Pete Stavropoulos with lowest potential downside - -$0

Annexon  in the News

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current Standards of Care in Matched Patient Populations New Analyses of Phase 3 Trial Highlight Tanruprubart’s Early and Durable Treatment Effect and Improvement in Quality of Life in Patients...

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward™ (MoveGBSForward.com) Highlights Life-altering Impact of GBS BRISBANE, Calif., April 08, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?